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Abstract
Context: The surgical management of benign prostatic hyperplasia (BPH) is evolving away from open surgery. In 
developing countries however majority of cases are managed by transvesical prostatectomy (TP).
Aims: This study aims to describe our experience regarding the efficacy, complication profile and outcome of TP in 
the management of BPH in Nigeria.
Settings and Design: A descriptive, retrospective study carried out in three tertiary centers.
Subjects and Methods: Two hundred and ninety-seven patients were studied. Parameters examined included age, 
clinical features, investigations, type of postoperative bladder irrigation, prostate gland volume, duration of hospital 
stay, complications and outcome.
Statistical Analysis Used: Simple means and percentages with SPSS 16.
Results: Mean age was 65.2 ± 6.8 years (range 47-93 years). Presentation with severe lower urinary tract symptoms 
only occurred in 76 patients (25.7%); acute urinary retention was seen in 106 patients (35.7%). Chronic urinary retention, 
impaired renal function and haematuria occurred in 47 (15.8%), 37 (12.5%), and 31 patients (10.4%) respectively. 
On comorbidity, 63 patients (21.2%) were hypertensive and 24 patients (8.1%) had diabetes mellitus. Two hundred and 
twenty three patients (75%) had indwelling catheters at the time of surgery. Preoperative urinary catheter duration was 
1 week-35 months. Mean duration of hospital stay was 8.8 days. Complications were transient urinary incontinence 
33 patients (11.1%), urinary tract infection 38 patients (12.7%), and acute epididymoorchitis 15 patients (5.1%). Clot 
retention occurred in 40 patients (13.5%). Mortality rate was 1%.
Conclusions: TP remains useful in developing climes. There is a need to emphasize effective preoperative workup 
so as to limit morbidity. Emphasis on variety of techniques for hemostasis is necessary.
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Introduction
Urinary bladder outlet obstruction secondary to benign 
prostatic hyperplasia (BPH) is a common problem in the 
sub‑Saharan region of Africa.[1] Patients often present 
when they have developed acute urinary retention (AUR), 
severe lower urinary tract symptoms (LUTS),[2] or other 
complications, despite having progressive diminishing 
caliber and strength of urinary stream for months.[1]
After relief of urinary retention, appropriate definitive 
treatment of the bladder outlet obstruction must be 
selected.[1] This would usually be pharmacologic treatment 
with attendant poor compliance due to the relatively high cost 
of the drugs, open prostatectomy or transurethral resection 
of the prostate (TURP). Frequently, patients are maintained 
on indwelling catheters as temporary measure before surgery.
In developed countries, TURP is the most frequently used 
modality of surgical treatment for BPH.[3] In sub‑Saharan 
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Africa, however, high cost of requisite technology, poor 
maintenance culture, and absence of clear policies for 
replacement of broken items, limits its usage to few tertiary 
centers. Where available, patients often lack resources to 
access TURP or sustained pharmacologic treatment,[4] 
thus open prostatectomy remains a useful option, even as 
migration to minimally invasive methods continue.
This study aims to describe our experience regarding the 
efficacy, complication profile and outcome of transvesical 
prostatectomy (TP) in the management of BPH in Nigeria.
Subjects and Methods
Between January 1997 and December 2010, 323 patients that 
had TP at the University of Nigeria Teaching Hospital, Royal 
Hospital and Saint Mary’s Hospital hospitals, were identified 
through ward admission registers and theatre registers. Of these, 
297 case notes were retrieved and evaluated using a data 
collection form. Information retrieved included patients’ age 
at presentation, clinical features, and investigations performed, 
intraoperative and postoperative details. Other clinical details 
collected were histopathology result, length of postoperative 
hospital stay, complications, and outcome. Research ethics 
committee approval was obtained. The data were analyzed 
using Statistical Package for Social Sciences SPSS version 
16 (SPSS Inc., Chicago, Illinois, U.S.A).
Results
The mean age of patients was 65.2 ± 6.8 years (range 
47‑93 years) [Table 1]. Patients were predominantly farmers 
136 (45.7%), while 83 (27.6%) and 78 (26.2%) were retired 
civil servants and traders, respectively. Patients’ presenting 
symptoms were severe LUTS in 25.7% (76 patients) and 
AUR in 35.7% (106 patients) [Table 2].
Digital rectal examination findings were commonly reported 
as enlarged and benign. Abdominal ultrasonography reports 
were available in 250 patients (84.1%) only. All showed 
features of benign enlargement with a mean volume of 
100.7 ml (range 71‑363). Twenty‑three (9.2%) showed 
features of hydroureter and hydronephrosis. Thickened 
bladder wall and diverticulum formation were seen in 
211 (84.4%) and 69 (27.6%) patients respectively. Urine 
culture results were available in 171 (57.6%) patients. 
Organisms isolated were Escherichia coli in 67 (22.6%), 
Pseudomonas in 24 (8.1%) and Staphylococcus aureus in 
12 (4.0%). No growth was reported in 68 (22.9%) patients.
Concerning co‑morbidity, 116 (39%) were hypertensive, 
24 patients (8.1%) were diabetic, eight (2.7%) had been 
treated for congestive cardiac failure, nine (3%) and 
five patients (1.7%) had chest pain/angina, and chronic 
obstructive airway disease respectively.
Intravenous urography (IVU) was done in 49 patients (16.4%) 
and the most frequent finding was elevation of the bladder 
base with prostatic filling defect. Postero‑anterior chest 
radiographs were done preoperatively in 177 patients and 
showed hypertensive changes (increased cardio thoracic 
ratio and aortic unfolding) in 58 patients (32.7%). Intra and 
postoperative blood transfusion was given to 91 patients.
One hundred and thirteen patients (38%) had indwelling 
catheters at the time of surgery, (97 urethral; 16 suprapubic). 
Reasons for catheter placement were failed trial without 
catheter (TWOC) post AUR in 74 patients (24.9%), 
obstructive nephropathy in 37 patients (12.4%), and 
significant gross hematuria in two patients (0.7%). Duration 
of preoperative indwelling urinary catheter use ranged from 
1 week to 35 months [Table 3].
Prophylactic antibiotics used were combination of 
ceftriaxone, gentamicin and metronidazole in 240 (80.8%) 
and ciprofloxacin/levofloxacin and metronidazole 
Table 1: Age range of patients








Table 2: Presenting symptoms of BPH seen
Symptom Number of patients Percentage
Storage LUTS 37 12.5
Voiding LUTS 21 7.1
Acute urinary retention 106 35.6
Chronic urinary retention 47 15.8
Hematuria 31 10.4
Impaired renal function 37 12.5
Mixed LUTS 18 6.1
Total 297 100.0
BPH=Benign prostatic hyperplasia; LUTS=Lower urinary tract symptoms
Table 3: Complications observed
Complication Number of patients Percentage
Clot retention 40 13.5
Wound infection 36 12.1
Urinary tract infection 38 12.7
Bladder calculi 49 16.5
Acute epididymoorchitis 15 5.1
Vesicocutaneous fistula 12 4.0
Transient incontinence 33 11.1
Bladder neck stenosis 19 6.4
Urethral stricture 9 3.0
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in the remainder. Spinal anesthesia was used in 
149 patients (50.2%), general anesthesia in 121 (40.7%) and 
epidural in 27 patients (9%). The mean duration of hospital 
stay from operation to discharge was 8.8 days, (range 
6‑29 days).
Some complications observed were mild transient urinary 
incontinence 33 (11.1%), urinary tract infection (UTI) 
38 (12.7%), acute epididymoorchitis 15 (5.1%) and clot 
retention in 40 patients (13.5%).
Duration of follow‑up was 4‑21 months (mean 8 months). 
Mortality rate was 1%.
Discussion
In the Western world, the surgical management of BPH 
continues to evolve with declining rates of TURP and 
increased use of various laser prostatectomy techniques.[5] 
In developing countries, most BPH surgery is done by the 
open approach with TURP constituting < 20%.[6] Despite 
this, open prostatectomy is attended by lower reoperation 
rate than TURP and similar mortality rates.[7] Some also 
suggest that TURP is attended by a higher mortality rate and 
may be less effective than open prostatectomy in relieving 
urinary obstruction from BPH.[8]
The mean age of patients in our series was 65 years which is 
similar to that of earlier studies.[4,6] Common presentations 
were severe LUTS, AUR, chronic urinary retention, gross 
hematuria and renal impairment. This agrees with earlier 
observations,[1,2,4] and may be a reflection of poor access to 
healthcare and poor health seeking behaviour.
Over a third of our patients had indwelling urethral 
catheters at the time of surgery. The leading indication for 
catheter placement was recurrent AUR (failed TWOC) 
and significant gross hematuria. This high occurrence of 
preoperative catheterization was noted by Meier et al.,[1] 
and others.[2,4] Though the most frequently observed 
preoperative catheter time in our series was 2‑4 weeks, 
we noted that 47.7% had indwelling catheter duration of 
between 5 months and 35 months. Problems of long catheter 
time such as UTI, bleeding, vicarious denial of sexual 
intercourse and urethral discomfort have been observed by 
other authors.[9] We noted preoperative UTI and bleeding 
in our series and suspect that the frequent requests for 
catheter removal preoperatively may be to facilitate sexual 
intercourse. Patients also complained often of urethral 
discomfort attributable to the catheter.
Regarding urine culture, the commonest isolate was E. coli, 
seen mostly in those patients with indwelling catheters. This 
is similar to the findings of Heyns who noted that BPH was 
associated with preoperative bacteriuria and this was worsened 
by preoperative catheterization as well as duration of same.[10] 
Ultrasonography was done most often due to its availability, 
low cost and nonrequirement for special preparation. 
Ultrasound assessment of prostate volume interestingly 
revealed a mean volume of 100.7 ml (range 71‑363). Though 
there was paucity of data about prostatectomy specimen 
weight, these ultrasonic assessments may suggest that our 
study population had significantly large prostatic volumes. 
A study of ultrasonic determination of prostate volume in 
men with symptomatic BPH had revealed a mean volume 
of 83.79 ml,[11] which was higher than similar studies from 
the West that reported lower prostate volumes.[12] These 
observations may suggest the continued relevance of open 
prostatectomy in developing climes, without necessarily 
retarding the emergence of endoscopic techniques. It is 
also noteworthy that 84.4% of patients (211) and 27.6% 
(69) patients showed evidence of bladder wall thickening and 
bladder diverticulum respectively. This relates to the severity 
of symptoms as suggested by other workers,[13] and appears to 
suggest that late presentation may be the norm in our setting. 
The finding of 7.7% of patients with hydronephrosis is also in 
keeping with an earlier determined incidence of upper tract 
complications in BPH.[14]
Intravenous urography was done in 49 patients (16.4%), 
and the most frequent finding was elevation of the bladder 
base. The common indications for requesting IVU were 
preoperative hematuria, calculus and surgeon preference. 
Those without preoperative IVU were not observed to have 
other lesions discovered intraoperatively. This observation 
seemed to support earlier findings[14,15] that concluded that 
routine preoperative IVU adds little value to the diagnostic 
workup and may be dispensed with.[16]
Earlier authors had reported various blood transfusion rates 
of up to 31‑36.8%.[17,18] We noted a blood transfusion rate of 
30.6% that is similar to earlier findings.[17,18] Our observed 
blood transfusion rate may be due to the fact there was no 
uniform hemostatic technique adopted in all cases, large 
prostate size may also have been contributory. Furthermore, 
transfusion triggers were not uniformly set and varied widely 
between cases. This calls for clearly defined transfusion 
triggers and the wider use of adjunctive hemostatic 
techniques. We observed that 36 of these patients received 
only one unit blood which meant in our view that the 
transfusion was probably not required. This raised the issue 
of transfusion trigger. Exclusion of this no would have given 
a transfusion rate of 18.5%. Postoperative bladder irrigation 
was by the “through and through” method (combination of 
urethral and suprapubic catheter) in majority of cases. This 
appeared to be because of an observed lower incidence of 
catheter blockage and may be useful in developing countries 
where workload: Nursing staff numbers ratio is high.
Concerning comorbidity, the most commonly observed 
comorbid factors were hypertension and diabetes mellitus. 
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This is similar to the observations of others where a similar 
pattern of cardiovascular morbidity predominated.[2,4] 
Impaired renal function was managed preoperatively with 
urethral catheterization and continuous bladder drainage 
until creatinine levels returned to normal. This complication 
of renal impairment secondary to BPH was observed by Hill 
et al. who noted that return of renal function to normal 
after prostatectomy was not invariable and contributed 
to substantial postoperative morbidity.[19] We adopt the 
practice of allowing time for return of normal renal function, 
while on continuous bladder drainage. This is done on an 
outpatient basis and may reduce perioperative morbidity 
and mortality from renal failure.
Prophylactic ceftriaxone and genticin was used in majority 
of cases and ciprofloxacin only in the remainder. These 
regimens have been shown to reduce the incidence of 
bacteriuria and septicemia in men with preoperative sterile 
urine.[10] Many patients had long‑term indwelling catheters 
and positive urine culture at the time of surgery. This 
challenge may be remedied by better access to care.
Mean duration of hospital stay was 8.8 days. This is similar 
to the findings of Kiptoon et al.[6] Wound infection was a 
major contributor to hospital stay >8 days.
Some complications observed included mild transient 
urinary incontinence, wound infection and clot retention 
as also noted by Kiptoon et al.[6] The wound infection 
rate is probably attributable to preoperative bacteriuria of 
which long‑term catheterization contributed greatly. This 
was managed with regular change of dressing and culture 
directed antibiotic therapy. Clot retention rate was higher 
than the 0.9% noted by Hill,[2] but his series deployed 
the Malament suture in all cases. Mild transient urinary 
incontinence has been noted to be the “Achilles heel” of 
the transvesical procedure;[2] this resolved in all cases with 
pelvic floor exercises.
Vesicocutaneous fistula occurrence was similar to that 
noted by others[2] and resolved on catheter drainage only. 
Bladder neck stenosis was seen in 6.4% of patients in this 
series. Earlier workers had shown a rate of between 8.6% 
and 13.9%, respectively.[20] When observed it requires 
open or endoscopic revision. Some long segment anterior 
urethral strictures were observed after prostatectomy. This 
is probably due to poor quality latex catheters that induce 
an intense urethral inflammation resulting in stricture. 
The toxicity of latex has been shown previously and it has 
been suggested that it should no longer be used for urinary 
catheters.[21,22]
A mortality rate of 1% is comparable to other series.[4,18] 
One case had significant postoperative hemorrhage, this 
was also observed by Ngugi and Saula[18] and highlights 
the need for awareness of this potential complication and 
deploy preventive hemostatic maneuvers. Another mortality 
occurred as a result of pulmonary embolism, which has been 
associated with open prostatectomy.[23]
Conclusion
The utility and relevance of open prostatectomy in 
developing climes remain valid. There is a need to emphasize 
the value of good preoperative workup and anticipation of 
possible challenges in order to limit morbidity. Long‑term 
preoperative catheterization should be avoided where 
feasible. Hemostatic techniques should be highlighted in 
training in the event they are required.
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